Reply: When to call it severe mitral regurgitation?

Paul A. Grayburn, Blasé Carabello, Judy W. Hung, Linda D. Gillam, David Liang, Michael J. Mack, Patrick M. McCarthy, D. Craig Miller, Alfredo Trento, Robert J. Siegel

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)2767-2768
Number of pages2
JournalJournal of the American College of Cardiology
Volume65
Issue number25
DOIs
StatePublished - Jun 30 2015

Funding

Please note: Dr. Grayburn has received grant support from Abbott Vascular and Medtronic ; has served as a consultant for Abbott Vascular, Tendyne, and Bracco Diagnostics; and has had Echo Core Lab contracts for ValTech Cardio, Guided Delivery Systems, and Tendyne. Dr. Gillam has had Core Lab Research contracts for Edwards Lifesciences and Medtronic. Dr. Liang serves on the medical advisory board for and has received research support from Philips Healthcare . Dr. McCarthy has served as a consultant for Edwards Lifesciences, and is an inventor of IMR ETlogix. Dr. Miller has served on the PARTNER Executive Committee for Edwards Lifesciences; has served as a consultant for Medtronic CardioVascular Division and Abbott Vascular Structural Heart (MitraClip); and has served on the scientific advisory board for GenTAC. Dr. Siegel has served as a speaker for Philips and Abbott Vascular. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this